Synthesis of ansa1-cytidines

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Nucleoside Chemistry

Background:

• Ansa-nucleosides are modified nucleosides with potential therapeutic applications.
• Cytidine analogs are crucial in antiviral and anticancer drug development.
• Pyrrolo[2,3-d]pyrimidine derivatives represent a significant class of nucleobase analogs.

Purpose of the Study:

• To describe the synthesis of novel ansa(1)-N(4)5-ethylene cytidines.
• To investigate the challenges associated with the ring closure step in synthesizing the pyrrolo[2,3-d]pyrimidine core.
• To evaluate the biological activities of the newly synthesized compounds.

Main Methods:

• Chemical synthesis of ansa(1)-N(4)5-ethylene cytidines.
• Characterization of synthetic intermediates and final products.
• Assessment of biological activity through relevant assays.

Main Results:

• Successful synthesis of new ansa(1)-N(4)5-ethylene cytidines, including 3-ss-D-ribofuranosyl-3,5,6,7-tetrahydro-2H-pyrrolo[2,3-d]pyrimidin-2-one.
• Identification of difficulties encountered during the ring closure to form the target pyrrolo[2,3-d]pyrimidine base.
• Demonstrated lack of significant biological activities for the synthesized ansa(1-) cytidines.

Conclusions:

• The synthesis of novel ansa(1)-N(4)5-ethylene cytidines was achieved, presenting synthetic challenges.
• The newly synthesized compounds did not exhibit notable biological activities.
• Further research may be needed to optimize synthetic routes or explore structural modifications for biological efficacy.